Edition:
United Kingdom

Innovate Biopharmaceuticals Inc (INNT.OQ)

INNT.OQ on NASDAQ Stock Exchange Capital Market

6.18USD
20 Jul 2018
Change (% chg)

$-0.38 (-5.79%)
Prev Close
$6.56
Open
$6.59
Day's High
$6.59
Day's Low
$6.06
Volume
84,528
Avg. Vol
93,221
52-wk High
$50.50
52-wk Low
$3.43

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.760
FY 2017 Dec '17 0.61 -2.953
Sep '17 0.14 -1.611
Jun '17 0.19 -1.939
Mar '17 0.95 -2.804
FY 2016 Dec '16 1.07 -1.586
Sep '16 0.78 -2.655
Jun '16 1.68 -1.538
Mar '16 0.54 -2.333
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 0.00 0.00 0.00 --
Quarter Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-19 2 1.35 2.70 0.00 --
Earnings (per share)
Quarter Ending Sep-18 2 -0.23 -0.23 -0.23 --
Quarter Ending Dec-18 2 -0.26 -0.25 -0.27 --
Year Ending Dec-18 2 -1.40 -1.37 -1.43 --
Year Ending Dec-19 2 -0.92 -0.41 -1.43 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.33 32.76
P/E High - Last 5 Yrs. -- 298.33 45.44
P/E Low - Last 5 Yrs. -- 91.43 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 1.94 112.52 5.73
Price to Book (MRQ) -- 15.54 5.47
Price to Tangible Book (MRQ) -- 14.64 7.05
Price to Cash Flow (TTM) -- 72.59 23.29
% Owned Institutions 1.38 14.53 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.35 43.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -88.89 408.02 8.01
Sales (TTM) vs TTM 1 Yr. Ago -61.60 79.88 5.64
Sales - 5 Yr. Growth Rate -- 32.06 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -26.12 29.02 20.60
EPS (TTM) vs TTM 1 Yr. Ago 4.49 -- --
EPS - 5 Yr. Growth Rate -- 39.49 10.66
Capital Spending - 5 Yr. Growth Rate -- 39.97 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.15 1.92 2.22
Current Ratio (MRQ) 0.31 5.50 3.03
LT Debt to Equity (MRQ) -- 34.92 12.51
Total Debt to Equity (MRQ) -- 36.72 16.84
Interest Coverage (TTM) -3.93 -101.16 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 5.80 39.68 54.37
Gross Margin - 5 Yr. Avg. -- 50.98 52.17
EBITD Margin (TTM) -248.84 -- --
EBITD - 5 Yr. Avg -- -586.56 10.81
Operating Margin (TTM) -232.32 -733.21 4.58
Operating Margin - 5 Yr. Avg. -- -608.15 6.24
Pre-Tax Margin (TTM) -233.62 -707.36 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -611.67 6.68
Net Profit Margin (TTM) -233.69 -708.75 1.73
Net Profit Margin - 5 Yr. Avg. -- -614.69 2.95
Effective Tax Rate (TTM) -- 23.23 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.56 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,025,841 860,395,327
Net Income/Employee (TTM) -- 3,117,868 101,209,600
Receivable Turnover (TTM) 4.77 20.74 5.87
Inventory Turnover (TTM) 3.44 2.46 3.41
Asset Turnover (TTM) 0.63 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -147.16 0.27 11.14
Return on Assets - 5 Yr. Avg. -- 3.72 12.40
Return on Investment (TTM) -- 2.22 14.61
Return on Investment - 5 Yr. Avg. -- 2.89 16.14
Return on Equity (TTM) -- 3.86 16.34
Return on Equity - 5 Yr. Avg. -- 3.83 17.40
  1 Year 3 Year 5 Year
Sales % -50.82 5.68 --
EPS (TTM) % -3.76 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Innovate Biopharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.62%
# of Holders: 22
Total Shares Held: 1,444,713
3 Mo. Net Change: 19,973
# New Positions: 5
# Closed Positions: 0
# Increased Positions: 6
# Reduced Positions: 0
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.